Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T10217L |
Abarelix
R3827,阿巴瑞克,PPI 149 |
GNRH Receptor | GPCR/G Protein |
Abarelix (PPI 149) 是一种促性腺激素释放激素 (GnRH) 拮抗剂,用于前列腺癌研究。 | |||
T10217 |
Abarelix Acetate (183552-38-7 free base)
PPI 149 Acetate,Abarelix Acetate |
Others | Others |
Abarelix (PPI 149; R 3827) Acetate is a potent gonadotrophin-releasing hormone (GnRH) antagonist, used for prostate cancer research. | |||
T68701 | Abarelix acetate | ||
Abarelix acetate is a synthetic third generation gonadotropin-releasing hormone receptor (GnRHR) antagonist. It increases histamine release from rat peritoneal mast cells in vitro and from a human skin model ex vivo. In vivo, abarelix decreases plasma luteinizing hormone (LH) levels six hours post-treatment in castrated rats, with levels returning to baseline within 24 hours.3 Abarelix (2 mg/kg) also transiently decreases plasma testosterone levels in intact rats, with levels returning to baseli... |